Medical and diagnostic laboratory services are services that provide diagnostics tests for various diseases. The tests are used for detecting if the person has encountered the disease. Medical and diagnostic laboratory services makes it possible to deliver prompt, affordable, and high-quality diagnostic services in secure settings. The main types of medical and diagnostic laboratory services are diagnostic imaging centres and medical laboratory services. A diagnostic imaging center is a service provider that offers technical or comprehensive diagnostic imaging services. The different expenditure types include public and private that are used in various applications such as cardiology, oncology, neurology, orthopedics, gastroenterology, gynecology, and others. The services are used by males and females. The medical and diagnostic laboratory services market research report is one of a series of new reports from The Business Research Company that provides medical and diagnostic laboratory services market statistics, including medical and diagnostic laboratory services industry global market size, regional shares, competitors with a medical and diagnostic laboratory services market share, detailed medical and diagnostic laboratory services market segments, market trends and opportunities, and any further data you may need to thrive in the medical and diagnostic laboratory services industry. This medical and diagnostic laboratory services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global medical and diagnostic laboratory services market grew from $169.87 billion in 2022 to $183.84 billion in 2023 at a compound annual growth rate (CAGR) of 8.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The medical and diagnostic laboratory services market is expected to grow to $240.86 billion in 2027 at a CAGR of 7.0%. The rise in sedentary jobs, busy lifestyles, and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes, and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of chronic diseases such as diabetes. According to the World Health Organization, chronic disease prevalence rose by 57% globally, in 2020. Tests to diagnose these diseases include HbA1c tests for monitoring diabetes, biopsies, tumor marker tests, bone scans, MRI and CT scans for diagnosis of various cancers, electrocardiograms, chest X-rays, cardiac CT scans, and stress tests for detection of cardiovascular diseases. The increase in the prevalence of lifestyle diseases will increase the demand for tests to diagnose these diseases and thus will drive the medical and diagnostic laboratory services market during the forecast period. The medical and diagnostic laboratory services market is expected to limit by the rising prevalence of self-care diagnostic equipment. These tools can be used by patients without assistance from medical personnel, to diagnose particular disabilities or disorders. Common self-care diagnostic devices include glucose monitoring devices, blood pressure monitoring devices, sleep apnea monitors and temperature monitors. The ease of use of self-care devices has increased demand for them during the last decade and is expected to increase it further during the forecast period. Some virtual applications are also aiding in the diagnosis of certain health conditions. For instance, iPhone is working on an IOS accessory called Cue, which can be used as a home diagnostic kit. Self-care diagnostics is expected to have a negative impact on the traditional medical and diagnostic laboratory services market during the forecast period by reducing the need for laboratory testing for some basic tests. Medical and diagnostic laboratories are using biomarkers to measure health parameters associated with individual wellness. The health and well-being of individuals can be measured by using biomarkers to assess factors behind sleep disorders and symptoms of stress. Biomarkers such as cortisol, testosterone, and secretory IgA can indicate changes in the immune system relating to physical and mental conditions. This can be used by physicians to know the causative factors behind such conditions. This is a premium service primarily targeted at wealthy individuals and senior employees of corporations. Major companies in the medical and diagnostic laboratory services market include Laboratory Corporation of America, Eurofins, Quest Diagnostics Incorporated, Sonic Healthcare Limited, Kaiser Permanente, RadNet, OPKO Health, Myriad Genetics, Charles River Laboratories, Inc., and NeoGenomics Laboratories, Inc. North America was the largest region in the medical and diagnostic laboratory services market in 2022. Asia-Pacific was the second largest region in the medical and diagnostic laboratory services market. The regions covered in the medical and diagnostic laboratory services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical and diagnostic laboratory services market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The medical and diagnostic laboratory services market includes revenues earned by entities by providing diagnostic services such as diagnostic laboratory services, X-ray, CT scan, and Mammography. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global medical and diagnostic laboratory services market is segmented - 1) By Type: Diagnostic Imaging Centers, Medical Laboratory Services 2) By Application: Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, Other Applications 3) By End User Gender: Male, Female 4) By Type of Expenditure: Public, Private Subsegments Covered: Computer Tomography (CT-Scan) Centers, Medical Radiological Laboratories, Dental or Medical X-Ray Laboratories, Ultrasound Imaging Centers, Magnetic Resonance Imaging (MRI) Centers

The engineered stone refers to a composite slab of stone that is prepared from 90% crushed quartz and that is bound together utilizing a polymer resin, and the rest of 10% is prepared with extra materials such as metals, mirrors, or colored glass that are mixed in for aesthetic reasons. The engineered stone is utilized anywhere that slab stones such as marble or granite are used, but a majority of customers and industries utilize engineered stone for their kitchen and bathroom countertops. The key types of engineered stone products include tiles, blocks, and slabs, manufactured using processes such as cold-curing and hot-curing. Tiles, blocks, and slabs manufactured from engineered stone are used across a broad range of furnishing applications like kitchen worktops, flooring, raised flooring, internal and external cladding, vanity tops, and bathroom furnishings for little or large, public or private projects for houses and enormous commercial areas. The key applications of engineered stone include kitchen countertops, bathroom countertops, flooring, facades, and walls. The engineered stone research report is one of a series of new reports from The Business Research Company that provides engineered stone statistics, including engineered stone industry global market size, regional shares, competitors with engineered stone shares, detailed engineered stone segments, market trends and opportunities, and any further data you may need to thrive in the engineered stone industry. This engineered stone research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global engineered stone market size grew from $22.48 billion in 2022 to $24.52 billion in 2023 at a compound annual growth rate (CAGR) of 9.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The engineered stone market size is expected to grow to $34.36 billion in 2027 at a CAGR of 8.8%. The high growth in the construction industry is expected to propel the growth of the engineered stone market. Engineered stones are widely used in the construction of residential projects for kitchen countertops, floors, façade tiles, and other architectural applications. The added benefits of engineered stone, such as bacteria-resistant nature, scratch-resistant nature, and heat resistance, make them an ideal choice for residential and commercial construction projects. The rapid surge in construction of commercial and residential projects is expected to boost the usage of engineered stones during the forecast period. For instance, according to the Office of National Statistics UK, the monthly construction output increased by 3.5% in volume in November 2021. Also, according to Invest India, an India-based national investment promotion and facilitation agency, the construction industry in India is expected to reach $1.4 trillion by 2025. The key players in the engineered stone market are focusing on the manufacturing and development of engineered stone from recycled materials to meet their efforts towards sustainability and a low-carbon future. For instance, in March 2021, Stone Italiana, an Italy-based manufacturer of engineered stone, launched a new range of engineered stone called Cosmolite, manufactured from inert pre-consumer recycled materials. This stone was certified with LEED v4 Green Gold, NSF 51 Food Contact and the ability to produce low volatile organic compound emissions. In September 2020, The Engineered Stone Group, an Australian-based company, acquired F & D Group, a Europe-based company involved in the manufacturing of engineered stone shower trays and washbasins, for an undisclosed amount. This acquisition helps position the ES Group as a leader in the engineered stone bathroom products space, a developing segment within the broader bathroom products market. Major players in the engineered stone market are LG Hausys, Johnson Marble & Quartz, Technistone A.S., Caesarstone Ltd., Belenco, Quarella Group Ltd., Quartzforms, Stone Italiana S.p.A, VICOSTONE, Diresco, Viatera, Santa Margherita Spa, Silestone, Tchnistone, and Topzstone. Asia-Pacific was the largest region in the engineered stone market in 2022. The regions covered in the engineered stone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the Engineered Stone market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The engineered stone market consists of sales of Caesarstone, dekton, quartz, and Silestone. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global engineered stone market is segmented - 1) By Type: Tiles and Blocks, Slabs 2) By Process: Cold Curing, Hot Curing 3) By Application: Kitchen Countertops, Bathroom Countertops, Flooring, Facades, Walls

Orthopedic biomaterials are materials intended to be inserted into the human body as constituents of devices designed to perform certain biological functions by either substituting or repairing various tissues, such as bones, cartilage, ligaments, tendons, and others. The orthopedic biomaterials market covered in this report is segmented by material type into ceramics and bioactive glasses, calcium phosphate cement, polymers, metal, and composites. Polymers are used as orthopedic biomaterials intended to be inserted into the human body as constituents. The various applications are orthopedic implants, joint replacement/reconstruction, bio-resorbable tissue fixation, orthobiologics, and viscosupplementation. These are used by various end-users such as hospitals, clinics, and others. The orthopedic biomaterials market research report is one of a series of new reports from The Business Research Company that provides orthopedic biomaterials market statistics, including orthopedic biomaterials industry global market size, regional shares, competitors with a orthopedic biomaterials market share, detailed orthopedic biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the orthopedic biomaterials industry. This orthopedic biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global orthopedic biomaterials market grew from $16.9 billion in 2022 to $18.62 billion in 2023 at a compound annual growth rate (CAGR) of 10.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The orthopedic biomaterials market is expected to grow from $29.69 billion in 2027 at a CAGR of 12.4%. The rise in the incidence of musculoskeletal disorders is expected to drive the orthopedic biomaterials market. According to the World Health Organization (WHO) report, musculoskeletal conditions are the leading contributor to disability worldwide. About 20-33% of the population suffer from a musculoskeletal disability. Musculoskeletal disorders induce fractures, swelling, and discomfort in the joints, ligaments, and tendons that cause movement disabilities. The burden of musculoskeletal conditions is known to increase with age. The sustainable development goals (SDGs) and the Decade of Healthy Ageing 2020–2030 have called for increased global attention and action on musculoskeletal health. Biomaterials are used to treat these disorders. Hence, the incidence of musculoskeletal disorders is projected to drive the orthopedic biomaterials market. The high cost of conducting clinical trials is expected to hinder the biomaterials market growth. The orthopedic biomaterials are directly implanted in the body. Therefore, it is important to prove the safety and biocompatibility of these materials. However, the high cost of conducting clinical trials is acting as a major roadblock. The clinical studies are expensive and time-consuming due to the number of tests required, and the length of each test. The investment of resources, time, and funding grows with successive stages. Additional costs are associated with the result of the trials at different phases. For instance, the cost of a failed phase 3 trial is not just the cost associated with the trial itself but the cost of all prior trials as well as the cost of lost time pursuing a potentially viable alternative or repeating the steps. Therefore, the high cost of conducting clinical trials is expected to impact the orthopedic biomaterials market. 3D printing of orthopedic implants is one of the recent developments in the orthopedic biomaterials market. 3D printing technology is used to produce a large range of medical equipment, such as those with complicated structures or characteristics to suit a patient’s particular anatomy. 3D printing of orthopedic implants enables the design of more natural anatomical shapes, as well as the design of porous bone replacement scaffolds that can be easily integrated into the design of the implant. This allows natural bone regeneration to generate higher reliability of the implant. 3D printing of orthopedic implants is a trend in the orthopedic biomaterial market that is attracting many players. For instance, Evonik, a Germany-based chemical company has invested in Meditool, a Chinese-based 3d printed implant start-up that produces models and implants by using polyether ketone (PEEK) polymer supplied by Evonik. In November 2020, Olympus, a Japanese medical technology company, acquired FH Ortho for an undisclosed amount. The acquisition would help Olympus to grow in the field of orthopaedic minimally invasive surgery. FH Ortho is a France based orthopaedics company. Major players in the orthopedic biomaterials market are Zimmer Biomet Holdings Inc., Stryker Corporation, Victrex PLC (Invibio Ltd.), Globus Medical Inc., CAM Bioceramics B.V., Heraeus Holding GmbH, Exactech Inc., Collagen Matrix Inc., Evonik Industries AG, and Koninklijke DSM N.V. (DSM Biomedical B.V.). North America was the largest region in the orthopedic biomaterials market in 2022. Western Europe was the second largest region in the global orthopedic biomaterials market report. The regions covered in the global orthopedic biomaterials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the orthopedic biomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The orthopedic biomaterials market consists of sales of glass-ceramic and bioactive glasses and calcium phosphate cements. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global orthopedic biomaterials market is segmented - 1) By Material Type: Ceramics & Bioactive Glasses, Calcium Phosphate Cements, Polymers, Metal, Composites 2) By Application: Orthopedic Implants, Joint Replacement/Reconstruction, Bio-Resorbable Tissue Fixation, Orthobiologics, Viscosupplementation 3) By End-User: Hospitals, Clinics, Other End-Users

An implantable biomaterial is a natural or synthetic material that is used in medical applications to support, enhance, or replace damaged tissue or a biological structure. The main materials in the implantable biomaterials are the materials such as metallic, ceramic, polymers, and natural. Metallic implants in implantable biomaterials refer to the component that is widely selected for orthopedic prosthesis over polymeric biomaterials and traditional ceramic materials and is used for the enhancement of biological activities. The various applications include dental, cardiovascular, ophthalmology, orthopedic, and others. These are used in hospitals, ambulatory surgical centres, and specialty clinics. The implantable biomaterials market research report is one of a series of new reports from The Business Research Company that provides implantable biomaterials market statistics, including implantable biomaterials industry global market size, regional shares, competitors with a implantable biomaterials market share, detailed implantable biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the implantable biomaterials industry. This implantable biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global implantable biomaterials market grew from $113.64 billion in 2022 to $127.97 billion in 2023 at a compound annual growth rate (CAGR) of 12.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The implantable biomaterials market is expected to grow from $198.4 billion in 2027 at a CAGR of 11.6%. The allocation of funds by government organizations in the development of new biomaterials [SR1] contributed to the implantable biomaterials market growth. For instance, Drexel University granted USD 200,000 to the National Science Foundation for research on biomaterial-mediated control over macrophage behavior that affects biomaterial vascularization. The support from government organizations in the development of new biomaterials will drive the implantable biomaterials market. Limitations of biomaterial-based products are a major challenge for the implantable biomaterials market. For instance, metal biomaterials can corrode due to chemical reactions within the body such as enzymes and acids or it can also cause some metal ion toxicity in the body. Polymer biomaterial implants have intensive interaction with the body and can lead to wear and tear and can absorb the important nutrients and water from the blood. Some biomaterial implants can also minimize bone ingrowth or sometimes, implants can loosen over time and become dislodged. These reactions that biomaterials have with the body restrain their use thereby negatively impacting the implantable biomaterials market's growth. Major companies in the implantable biomaterials market are implementing 3D printing of biomaterials in manufacturing. For instance, Evonik is producing 3D printable biomaterials for medical technology that are used for manufacturing medical implants with permanent body contact and temporary body contact line of bioresorbable filaments and powders. Implants with permanent body contact are based on Vestakeep Peek, and with the temporary body, contact is based on Resume. In April 2022, Integer Holdings Corporation, a US-based medical device company, acquired Connemara Biomedical Holdings Teoranta for an undisclosed amount. The acquisition would bring implantable biomaterial technology to Integer’s control and help its growth. Connemara Biomedical Holdings Teoranta is a Ireland-based manufacturer of biomaterials for cardiovascular implants. Major players in the implantable biomaterials market are Evonik Industries AG, Royal DSM, Zimmer Biomet Holdings, Carpenter Technology Corporation, Collagen Matrix, Corbion, BASF SE, Invibio Ltd., and Celanese Corporation. North America was the largest region in the implantable biomaterials market in 2022. Western Europe was the second largest region in the global implantable biomaterials market report. The regions covered in the global implantable biomaterials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the implantable biomaterials market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and USA. The implantable biomaterial market consists of sales of glass-ceramic and bioactive glasses and calcium phosphate cements. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global implantable biomaterials market is segmented - 1) By Material: Metallic, Ceramic, Polymers, Natural 2) By Application: Dental, Cardiovascular, Ophthalmology, Orthopedic, Other Applications 3) By End-user: Hospitals, Ambulatory Surgical Centers, Specialty Clinics

Thermal interface materials are defined as materials made from conducting materials such as metals, silicon, and metal oxides and are applied between hard surfaces for conducting heat. Thermal interface materials find their applications mainly in electronics, medical devices, and industrial machinery. The main types of thermal interface materials (TIMs) are greases & adhesives, tapes & films, gap fillers, metal based TIMs, and phase change materials. Metal-based TIMs are substances that absorb or release latent heat when they change their physical state from solid to liquid. TIMs are generally composed of silicone, epoxy, and polyimide and are used in several sectors, including telecom, computer manufacturing, medical devices, industrial machinery, consumer durables, and automotive electronics. The thermal interface materials market research report is one of a series of new reports from The Business Research Company that provides thermal interface materials market statistics, including thermal interface materials industry global market size, regional shares, competitors with a thermal interface materials market share, detailed thermal interface materials market segments, market trends and opportunities, and any further data you may need to thrive in the thermal interface materials industry. This thermal interface materials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global thermal interface materials market size grew from $2.21 billion in 2022 to $2.5 billion in 2023 at a compound annual growth rate (CAGR) of 13.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The thermal interface materials market size is expected to grow to $4.15 billion in 2027 at a CAGR of 13.5%. The increasing demand for electronic devices is anticipated to boost the demand for the thermal interface materials market over the coming years. Growing usage of thermal interface materials in electronic devices such as tablets, computers, smartphones, and video games attributed to its thermal conductive properties that help in strengthening the efficiency and life of electronic devices is expected to contribute to the market growth. For instance, in April 2020, according to a market figure published by gfu Consumer and Home Electronics GmbH, a Germany-based consumer electronics company, stated that with 31.2 billion Euros in sales in 2021, the consumer electronics segment is up 2.5% from 2020. Additionally, the segment of IT goods for private use grew positively, increasing by 3.1% to 8.7 billion euros. Therefore, the surge in demand for electronics devices and appliances is expected to generate higher revenues for the thermal interface materials market. The COVID-19 outbreak is a major factor that limited the growth of the thermal interface materials market. The spike in the number of people suffering from COVID-19 enforced the government to impose lockdowns, which in turn resulted in the temporary closure of many businesses and trade losses. Manufacturing projects were kept on hold due to social distancing practices and a lack of labour across the globe. The shutdown of thermal interface materials manufacturing sites and disruptions in supply chain and logistics significantly impacted the revenues of the market. For instance, according to the Engineering Export Promotion Council of India (EEPC), the estimated trade impact of the COVID-19 outbreak for India was approximately $348 million, and India is among the top 15 economies that were most affected as the manufacturing sector slowed down. Thus, the slowdown of the manufacturing sector due to COVID-19, including thermal interface materials, acted as a major restraint on market growth. Major players operating in the thermal interface materials market are focusing on developing new innovative products to expand their product portfolio, meet the requirements of various end-use industries, and maintain their position in the competitive business environment. For instance, in April 2020, Henkel AG & Co. KGaA introduced Loctite EA 9536 magnet bonding tape with easy assembly and high material extension for electric motors. It offers unique properties compared to the existing products in the market. The epoxy-based adhesive film can absorb oil and dirt and can be produced in various shapes and sizes customized to specific applications. The special epoxy resins create an elastic and strong bond that holds magnets securely in position. Moreover, in September 2020, Parker Hannifin Corporation, a US-based company specializing in control and motion technologies, launched THERM-A-GAP GEL 37, the next generation of single component and thermally conductive dispensable materials. The material has been specifically designed to limit the batch-to-batch differences typically found in thermal dispensable materials. In September 2022, Henkel, a Germany-based chemical and consumer goods company, acquired the Thermal Management Materials business of Nanoramic Laboratories for an undisclosed amount. With this acquisition of Nanoramic Laboratories, Henkel hopes to boost its adhesive technologies business unit's position in the emerging markets for thermal interface materials (TIM) by expanding its capabilities in high-performance segments. Nanoramic Laboratories is a US-based thermal interface materials solutions innovator and energy storage technology company. Major players in the thermal interface materials market are The 3M Company, Zalman Tech Co. Ltd., Wakefield-Vette Inc., Indium Corporation, The Berquist Company Inc., Momentive Performance Materials Inc., Laird Technologies Inc., DOW Corning Corporation, Parker Hannifin Corporation, Henkel AG & Co. KGAA, Fujipoly, DK Thermal Metal Circuit Technology Ltd., AI Technology, AIM Specialty Materials, AOS Thermal, Denka, Universal Science, Dymax Corporation, Ellsworth Adhesives, Enerdyne, European Thermodynamics Ltd., Inkron, Kitagawa Industries, LORD, MA Electronics, MH&W International, Minteq, Parker Chomerics, Resinlab, Schlegel Electronics Materials, and ShinEtsu. Asia-Pacific was the largest region in the thermal interface materials market in 2022. The regions covered in the thermal interface materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the thermal interface materials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The thermal interface materials market consists of sales of thermal tapes, greases, elastomeric pads, solders, and other thermal interface materials. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global thermal interface materials market is segmented - 1) By Type: Greases & Adhesives, Tapes & Films, Gap Fillers, Metal-Based TIMs, Phase Change Materials, Other Types 2) By Chemistry: Silicone, Epoxy, Polyimide, Other Chemistries 3) By Application: Telecom, Computer, Medical Devices, Industrial Machinery, Consumer Durables, Automotive Electronics, Other Applications

Nanomaterials refer to a type of material having internal structures of 100 nm or less or at least one exterior dimension that is 100 nm or less, and based on research, they use improvements in materials metrology and synthesis gained in favour of microfabrication studies to offer a materials science-based perspective on nanotechnology. The main material type of nanomaterials is carbon-based nanomaterials, metal & non-metal Oxides, metal-based nanomaterials, dendrimers nanomaterials, nano clay, nanocellulose, and others. The carbon-based nanomaterials are made of carbon nanotubes, graphene, and fullerenes. Carbon-based nanomaterials are used in biomedical fields such as biosensors, cancer therapy, tissue engineering, and delivery of therapeutics. The different types of structures include non-polymer organic nanomaterials, and polymeric nanomaterials and are used by various sectors such as paints and coatings, adhesives and sealants, health care and life science, energy, electronics, consumer goods, personal care, and other users. The nanomaterials market research report is one of a series of new reports from The Business Research Company that provides nanomaterials market statistics, including nanomaterials industry global market size, regional shares, competitors with a nanomaterials market share, detailed nanomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the nanomaterials industry. This nanomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global nanomaterials market size grew from $12.68 billion in 2022 to $14.65 billion in 2023 at a compound annual growth rate (CAGR) of 15.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The nanomaterials market size is expected to grow to $26.91 billion in 2027 at a CAGR of 16.4%. The increase in the usage of nanomaterials in the healthcare industry across the globe is contributing to the growth of the nanomaterials market. Nanomaterials are employed in the healthcare industry to target abnormalities in individual cells and even sub-cells and to boost the action of vaccinations and medicines by easily accessing the body. Hence, the demand for nanomaterials is rising with the increase in the application of nanomaterials in healthcare. For instance, according to the Press Trust of India (PTI), an India-based press company report published in 2021, worldwide, there are around 400 major nanotech companies of which, half of the companies are nanomedicine related. In addition, out of the total 30 to 40 major nanotech companies in India, half are related to healthcare. Therefore, the growing presence and usage of nanomaterials in the healthcare industry are expected to fuel the growth of the nanomaterials market over the forthcoming years. Product innovations are shaping the nanomaterials market. Major companies operating in the nanomaterials sector are focused on new product innovations to meet customers' demands and increase their market share. For instance, in 2020, Carnegie Mellon University launched a biosensing platform based on advanced nanomaterials. This biosensing platform identifies SARS-CoV-2 antibodies in a few seconds, a virus responsible for the COVID-19 pandemic. Not only testing but also the platform calculates the patient immunological response to the new vaccines. The biosensing platform based on advanced nanomaterials can also be used for the detection of other infectious diseases. In April 2020, Cabot Corporation, a US-based global specialty performance materials, and chemicals company acquired Shenzhen Sanshun Nano New Materials Co., Ltd (SUSN) for a $115 million deal amount. Through this acquisition, Cabot's market position and formulation skills in the high-growth batteries sector, especially in China, the world's strongest and quickest expanding electric vehicle market, have been greatly strengthened. Shenzhen Sanshun Nano New Materials Co., Ltd (SUSN) is a China-based company that manufactures carbon nanotubes (CNTs) and dispersions. Major players in the nanomaterials market are BASF SE, Bayer AG, Chasm Technologies Ltd., Cnano Technology, DuPont Air Products Nanomaterials LLC, Elmarco Ltd., Finetex ENE, Glonatech SA, Kuraray, Nanocyl SA, NanoViricides Inc., Sumitomo Corporation, Showa Denko, Zyvex Technologies, US Research Nanomaterials Inc., Nanocomposix Inc., Frontier Carbon Corporation, Nanoshel LLC, SkySpring Nanomaterials Inc., Cytodiagnostics Inc., Strem Chemicals Inc., and American Elements. North America was the largest region in the nanomaterials market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanomaterials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the nanomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The nanomaterials market consists of sales of inorganic-based nanomaterials, organic-based nanomaterials, nanofibers, and composite-based nanomaterials. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global nanomaterials market is segmented - 1) By Material Type: Carbon Based Nanomaterials, Metal And Non-Metal Oxides, Metal Based Nanomaterials, Dendrimers Nanomaterials, Nanoclay, Nanocellulose, Other Materials 2) By Structure Type: Non-Polymer Organic Nanomaterials, Polymeric Nanomaterials 3) By End User: Paint And Coatings, Packaging, Construction, Electronics And Consumer Goods, Other End-Users

Acoustic materials refer to a variety of foams, fabrics, metals, etc. used to quiet homes, offices, cars, and other structures to improve the comfort and safety of their occupants by reducing noise generated both inside and outside of those spaces. According to their properties, such as frequency, composition, thickness, surface finish, and mounting method, different types of materials are used for automotive acoustics. used to reduce the strength of mechanical waves such as sound, ultrasound, vibration, and infrasound in liquid, gas, and solid media. The main types of materials of automotive acoustic materials are acrylonitrile butadiene styrene (ABS), fiberglass, polyvinyl chloride (PVC), polyurethane (PU) foam, polypropylene, and textiles. Acrylonitrile butadiene styrene is an opaque amorphous and thermoplastic polymer. The different components include arch liner, dash, fender and floor insulator, door, head and bonnet liner, engine cover, trunk trim, parcel tray, and other components. The various types of vehicles include passenger cars, LCVs, and HCV. These are used in various applications such as underbody and engine bay acoustics, interior cabin acoustics, exterior acoustics, and trunk panel acoustics. The automotive acoustic materials market research report is one of a series of new reports from The Business Research Company that provides automotive acoustic materials market statistics, including automotive acoustic materials industry global market size, regional shares, competitors with an automotive acoustic materials market share, detailed automotive acoustic materials market segments, market trends, and opportunities, and any further data you may need to thrive in the automotive acoustic materials industry. This automotive acoustic materials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global automotive acoustic materials market size grew from $3.24 billion in 2022 to $3.5 billion in 2023 at a compound annual growth rate (CAGR) of 8.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The automotive acoustic materials market size is expected to grow to $4.71 billion in 2027 at a CAGR of 7.7%. The increase in sales of electric vehicles is expected to propel the growth of the automotive acoustic materials market going forward. Electric vehicles are vehicles that use electricity either entirely or in part. Automotive acoustic materials help electronic vehicles to reduce interior vehicle noise, by soundproofing and sound absorbing. According to the International Energy Agency (IEA) report in 2021, a France-based autonomous intergovernmental organization for energy, two-thirds of new electric car registrations and two-thirds of the stock in 2020 were battery electric vehicles (BEVs). Additionally, China has the greatest fleet size of electric vehicles with 4.5 million units and Europe experienced the largest annual growth, rising to 3.2 million in the year 2020. Therefore, the rising sales of electric vehicles are driving the growth of the automotive acoustic materials market. Technological advancements are the key trend gaining popularity in the automotive acoustic materials market. Major companies operating in the automotive acoustic materials market are introducing new technologies such as Flexi-Loft, a new felt-based technology that reduces product weight to sustain their position in the automotive acoustic materials market. For instance, in November 2021, Autoneum, a Switzerland-based developer of multifunctional, lightweight components and systems for interior floor and engine bay launched Flexi-Loft for vehicle interiors. This felt-based technology helps make a unique blend of recycled cotton and functional fibers reduces product weight and allows for accurate adaptation even to complex shapes. The textile material provides a versatile and more sustainable alternative to foam. In May 2020, Freudenberg Group, a Germany-based company offering tailor-made and technological products and services in the fields of automotive, automobile parts and more acquired Low & Bonar PLC. for an undisclosed amount. This deal is expected to help Freudenberg Group in strengthening its performance materials business and expands its technological know-how. Low & Bonar PLC., is a UK-based high-performance material manufacturer operating in the automotive acoustic materials market. Major players in the automotive acoustic materials market are Dow Chemicals, 3M Acoustics, BASF SE, Covestro AG, Henkel Adhesives Technologies India Private Limited, LyondellBasell Industries Holdings B.V., Sumitomo Riko, Sika AG, Rockwool A/S, Huntsman International LLC, Johns Manville, Saint-Gobain Ecophon AB, Harman International, Thomas Publishing Company, UFP Technologies Inc., Nihon Tokushu Toryo Co. Ltd., Knauf Insulation, and Owens Corning. Asia-Pacific was the largest region in the automotive acoustic materials market in 2022. The regions covered in automotive acoustic materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the automotive acoustic materials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The automotive acoustic materials market consists of sales of vibration dampers, vibration damping sheets, barrier decouplers, PVC decouplers, cellulose panels, sound silencers, silk metal, and echo barriers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global automotive acoustic materials market is segmented - 1) By Material Type: Acrylonitrile Butadiene Styrene (ABS), Fiberglass, Polyvinyl Chloride (PVC), Polyurethane (PU) Foam, Polypropylene, Textiles 2) By Component: Arch Liner, Dash, Fender and Floor Insulator, Door, Head & Bonnet Liner, Engine Cover, Trunk Trim, Parcel Tray, Other Components 3) By Vehicle Type: Passenger Cars, LCV, HCV 4) By Application: Underbody and Engine Bay Acoustics, Interior Cabin Acoustics, Exterior Acoustics, Trunk Panel Acoustics

Medical equipment are devices that can be instrument, apparatus or machine that can be used in the prevention, diagnosis or treatment of illness or disease, or for detecting, measuring, restoring, correcting or modifying the structure or function of the body for health purpose. The main types of medical equipment are in-vitro diagnostics, dental equipment and supplies, ophthalmic devices, diagnostic imaging equipment, cardiovascular devices, hospital supplies, surgical equipment, orthopedic devices, patient monitoring devices, diabetes care devices, nephrology and urology devices, ENT devices, anesthesia and respiratory devices, neurology devices, and wound care devices. In-vitro diagnostics are tests done on samples like blood or tissue that is taken from the human body. In-vitro diagnostics will detect diseases or other conditions and are used to monitor a person’s overall health to cure, treat, or prevent diseases. The type of expenditure involved is public and private. The various product are instruments/equipment and disposables. The various end users involved are hospitals and clinics, homecare, diagnostics centres, and others. The medical equipment market research report is one of a series of new reports from The Business Research Company that provides medical equipment market statistics, including medical equipment industry global market size, regional shares, competitors with a medical equipment market share, detailed medical equipment market segments, market trends and opportunities, and any further data you may need to thrive in the medical equipment industry. This medical equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global medical equipment market grew from $639.75 billion in 2022 to $695.05 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The medical equipment market is expected to grow to $922.39 billion in 2027 at a CAGR of 7.3%. The rise in sedentary jobs, busy lifestyles, and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes, and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of chronic diseases such as diabetes. According to the World Health Organization, chronic disease prevalence is expected to rise by 57% globally, by the year 2020. This is increasing the demand for medical devices used in the diagnosis, prognosis, and treatment of several diseases, thereby driving the demand for medical equipment. These factors are expected to increase the patient pool globally, thereby driving the market during the forecast period. Regulatory changes are likely to lead to increased costs relating to new product development and service offerings to clients. These changes are related to customer data protection such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures, and other regulatory changes. For instance, according to cookieyed data 2021, in the US, PwC reported that 68% of 200 businesses surveyed intended to spend between $1 million and $10 million to comply with GDPR regulations. The GDPR regulation is an EU law on data protection and privacy of individuals residing in the European Union and the European Economic Area (EEA). It also regulates the export of personal data outside the EU and EEA areas. Additionally, the FDA is requesting more clinical data to support claims, therefore increasing the time to process 510(k)s by over 55% over the last decade. The potential loss of revenue due to delays in product release and additional costs incurred due to stringent approval processes puts a strain on investments relating to new product development, thereby affecting the growth of the medical equipment market. Device performance and patient data are available to healthcare service providers and are helping them to improve patient monitoring and overall care quality. Some companies are integrating medical device data with EMR (Electronic Medical Records) to improve transparency and collaboration. As consumer wearables are becoming more common, patient data volumes are increasing and companies are investing in deploying data management, warehousing, and security technologies. For example, Medtronic launched a tool to augment their cardiac devices to securely transfer device data to doctors and allow them to monitor the critical health indicators of their patients. Major companies in the medical equipment market include Medtronic Inc., Abbott Laboratories, Johnson & Johnson, Cardinal Health, Inc., Becton Dickinson, Siemens AG, STRYKER CORPORATION, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., and Boston Scientific Corporation. North America was the largest region in the global medical equipment market in 2022. Asia-Pacific was the second largest region in the global medical equipment market. The regions covered in the medical equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the medical equipment market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The medical equipment market consists of sales of devices used in the diagnosis, treatment and monitoring of medical conditions. The market includes diagnostic devices, imaging devices, surgical devices and patient monitoring devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global medical equipment market is segmented - 1) By Type: In-Vitro Diagnostics, Dental Equipment And Supplies, Ophthalmic Devices, Diagnostic Imaging Equipment, Cardiovascular Devices, Hospital Supplies, Surgical Equipment, Orthopedic Devices, Patient Monitoring Devices, Diabetes Care Devices, Nephrology And Urology Devices, ENT Devices, Anesthesia And Respiratory Devices, Neurology Devices, Wound Care Devices 2) By Type of Expenditure: Public, Private 3) By Product: Instruments/Equipment, Disposables 4) By End User: Hospitals And Clinics, Homecare, Diagnostics Centers, Other End Users Subsegments Covered: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment, Therapeutic Dental Equipment, General Dental Devices And Equipment, Dental Diagnostic Imaging Devices And Equipment, Dental Surgical Devices And Equipment, Vision Care Devices And Equipment, Cataract Surgery Devices And Equipment, Refractive Surgery Devices And Equipment, Diagnostic And Monitoring Ophthalmic Devices And Equipment, X-Ray Systems Devices And Equipment, Ultrasound Systems Devices And Equipment, Computed Tomography (CT) Scanners Devices And Equipment, Magnetic Resonance Imaging Systems Devices And Equipment, Cardiovascular Monitoring And Diagnostic Devices And Equipment, Nuclear Imaging Devices And Equipment, Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment, Disposable Hospital Supplies, Sterilization Equipment And Disinfectants, Mobility Aids And Transportation Equipment, Operating Room Equipment, Surgical Sutures And Staples, Handheld Surgical Devices And Equipment, Electrosurgical Devices And Equipment, Joint Reconstruction Devices And Equipment, Spinal Surgery Devices And Equipment, Trauma Fixation Devices And Equipment, Orthobiologics Devices And Equipment, Arthroscopy Devices And Equipment, Orthopedic Braces And Support Devices And Equipment, Craniomaxillofacial (CMF) Devices And Equipment, Orthopedic Prosthetics, Orthopedic Accessories,, Fetal And Neonatal Monitoring Devices, Weight Monitoring And Body Temperature Monitoring Devices And Equipment, Vital Parameter Monitoring Devices And Equipment, Remote Patient Monitoring Devices And Equipment, Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters, Dialysis Devices And Equipment, Urinary Stone Treatment Devices And Equipment, Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment, Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment, Endoscopy Devices And Equipment, Hearing Aid Devices And Equipment, Hearing Diagnostic Devices And Equipment, ENT Surgical Devices And Equipment, Hearing Implants, Voice Prosthesis Devices And Equipment, Nasal Splints, Respiratory Devices And Equipment (Therapeutic And Diagnostic), Anesthesia Machines, Anesthesia Disposables, Respiratory Disposables, Cerebrospinal Fluid Management (CSF) Devices And Equipment, Interventional Neurology Devices And Equipment, Neurosurgery Devices And Equipment, Neurostimulation Devices, Traditional Adhesive Dressings, Negative-pressure Wound Therapy (NPWT), Traditional Gauze Dressings, Advanced Wound Care Devices